Makcef T 500mg/62.5mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Makcef T 500mg/62.5mg Injection
Cefixime and Sulbactam injection (500mg/62.5mg), a dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation, preventing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial. Complete the full course, even with symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Follow-up laboratory tests may be requested to monitor treatment response.
Uses of Makcef T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Makcef T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Makcef T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Makcef T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Makcef T 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactam 500mg/62.5mg (Makcef T) injection unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counters bacterial resistance, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Makcef T 500mg/62.5mg Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefixime and Sulbactam 500mg/62.5mg injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Cefixime and Sulbactam injection (500mg/62.5mg) requires careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Cefixime and sulbactam injection (500mg/62.5mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Makcef T 500mg/62.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Makcef T 500mg/62.5mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Makcef T 500mg/62.5mg Injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Makcef T 500mg/62.5mg Injection :
Should you forget a dose of Makcef T 500mg/62.5mg Injection, seek your physician's advice.
Facts to Know About Makcef T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently